Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2

Authors

Saba R. Aliyari, University of California, Los Angeles
Xiaochao Wei, Washington University School of Medicine in St. Louis
Clay F. Semenkovich, Washington University School of Medicine in St. Louis
et al.

Journal

Acta Pharmaceutica Sinica B

Publication Date

4-1-2022

Volume

12

Issue

4

First Page

1624

Last Page

1635

Document Type

Open Access Publication

DOI

10.1016/j.apsb.2022.02.019

Rights and Permissions

Aliyari SR, Ghaffari AA, Pernet O, Parvatiyar K, Wang Y, Gerami H, Tong AJ, Vergnes L, Takallou A, Zhang A, Wei X, Chilin LD, Wu Y, Semenkovich CF, Reue K, Smale ST, Lee B, Cheng G. Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2. Acta Pharm Sin B. 2022 Apr;12(4):1624-1635. doi: 10.1016/j.apsb.2022.02.019. ª 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Aliyari, Saba R.; Wei, Xiaochao; Semenkovich, Clay F.; and et al., "Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2." Acta Pharmaceutica Sinica B. 12, 4. 1624 - 1635. (2022).
https://digitalcommons.wustl.edu/oa_4/1496

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.